Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 299

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Mitochondrially targeted ZFN s for selective degradation of pathogenic mitochondrial genomes bearing large‐scale deletions or point mutations

Open access
Gammage, Payam A, Rorbach, Joanna, Vincent, Anna I, Rebar, Edward J, Minczuk, Michal·2014·EMBO Molecular Medicine

Abstract

We designed and engineered mitochondrially targeted obligate heterodimeric zinc finger nucleases (mt ZFN s) for site‐specific elimination of pathogenic human mitochondrial DNA (mt DNA ). We used mt ZFN s to target and cleave mt DNA harbouring the m.8993T>G point mutation associated with neuropathy, ataxia, retinitis pigmentosa ( NARP ) and the “common deletion” ( CD ), a 4977‐bp repeat‐flanked deletion associated with adult‐onset chronic progressive external ophthalmoplegia and, less frequently, Kearns‐Sayre and Pearson's marrow pancreas syndromes. Expression of mt ZFN s led to a reduction in mutant mt DNA haplotype load, and subsequent repopulation of wild‐type mt DNA restored mitochondrial respiratory function in a CD cybrid cell model. This study constitutes proof‐of‐principle that, through heteroplasmy manipulation, delivery of site‐specific nuclease activity to mitochondria can alleviate a severe biochemical phenotype in primary mitochondrial disease arising from deleted mt DNA species.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/emmm.201303672

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 299

Metadata

Authors
Gammage, P. A., Rorbach, J., Vincent, A. I., Rebar, E. J., & Minczuk, M.
Venue
EMBO Molecular Medicine
Published
2014-02-24
Volume
6
Issue
4
Pages
458-466
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W2107923677
Cited by
299
References
43
FWCI
6.57
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mitochondrially targeted ZFN s for selective degradation of pathogenic mitochondrial genomes bearing large‐scale deletions or point mutations. https://app.cochat.ai/papers/10.1002/emmm.201303672
The paper
Gammage, P. A., Rorbach, J., Vincent, A. I., Rebar, E. J., & Minczuk, M. (2014). Mitochondrially targeted ZFN s for selective degradation of pathogenic mitochondrial genomes bearing large‐scale deletions or point mutations. EMBO Molecular Medicine. https://doi.org/10.1002/emmm.201303672

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.